Joachim Widder

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

Joe Y. Chang, Suresh Senan, Marinus A. Paul et al. · The Lancet Oncology · 2015 · 1.5K citations · Full text

Medicine, Oncology, Radiation Oncology +8

Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach

Johannes A. Langendijk, Philippe Lambin, Dirk De Ruysscher et al. · Radiotherapy and Oncology · 2013 · 546 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Micro- and Nanoplastics Breach the Blood–Brain Barrier (BBB): Biomolecular Corona’s Role Revealed

Verena Kopatz, Kevin Wen, Tibor Kovács et al. · Nanomaterials · 2023 · 323 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study

Coen Hurkmans, J.P. Cuijpers, Frank J. Lagerwaard et al. · Radiation Oncology · 2009 · 284 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement

Matthias Gückenberger, Claus Belka, Andrea Bezjak et al. · Radiotherapy and Oncology · 2020 · 227 citations · Full text

Medicine, Oncology, Radiation Oncology +14